Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun 24:4:141-5.
doi: 10.2147/ppa.s10217.

Adherence issues related to sublingual immunotherapy as perceived by allergists

Silvia Scurati  1 , Franco Frati, Gianni Passalacqua, Paola Puccinelli, Cecile Hilaire, Cristoforo Incorvaia; Italian Study Group on SLIT Compliance
Collaborators, Affiliations

Adherence issues related to sublingual immunotherapy as perceived by allergists

Silvia Scurati et al. Patient Prefer Adherence. .

Abstract

Objectives: Sublingual immunotherapy (SLIT) is a viable alternative to subcutaneous immunotherapy to treat allergic rhinitis and asthma, and is widely used in clinical practice in many European countries. The clinical efficacy of SLIT has been established in a number of clinical trials and meta-analyses. However, because SLIT is self-administered by patients without medical supervision, the degree of patient adherence with treatment is still a concern. The objective of this study was to evaluate the perception by allergists of issues related to SLIT adherence.

Methods: We performed a questionnaire-based survey of 296 Italian allergists, based on the adherence issues known from previous studies. The perception of importance of each item was assessed by a VAS scale ranging from 0 to 10.

Results: Patient perception of clinical efficacy was considered the most important factor (ranked 1 by 54% of allergists), followed by the possibility of reimbursement (ranked 1 by 34%), and by the absence of side effects (ranked 1 by 21%). Patient education, regular follow-up, and ease of use of SLIT were ranked first by less than 20% of allergists.

Conclusion: These findings indicate that clinical efficacy, cost, and side effects are perceived as the major issues influencing patient adherence to SLIT, and that further improvement of adherence is likely to be achieved by improving the patient information provided by prescribers.

Keywords: adherence; cost; efficacy; side effects; sublingual immunotherapy.

PubMed Disclaimer

References

    1. Bousquet J, van Cauwenberge P. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(Suppl 5):147–334. - PubMed
    1. Compalati E, Penagos M, Tarantini F, et al. Specific immunotherapy for respiratory allergy: State of the art according to current meta-analyses. Ann Allergy Asthma Immunol. 2009;102:22–28. - PubMed
    1. Gidaro GB, Frati F, Sensi L, et al. The safety of sublingual-swallow immunotherapy: An analysis of published studies. Clin Exp Allergy. 2005;35:565–571. - PubMed
    1. Incorvaia C, Mauro M, Ridolo E, et al. Patient’s compliance with allergen immunotherapy. Patient Prefer Adherence. 2008;2:247–250. - PMC - PubMed
    1. Haynes RB, Sackett DL, Taylor DW. Compliance in Healthcare. Baltimore, MD: Johns Hopkins University Press; 1979.